Population-Based Prevalence of Chlamydia trachomatis Infection and Antibodies in Four Districts with Varying Levels of Trachoma Endemicity in Amhara, Ethiopia

• Published in: The American journal of tropical medicine and hygiene Vol. 104; no. 1; pp. 207 - 215
• Main Authors: Nash, Scott D, Astale, Tigist, Nute, Andrew W, Bethea, Danaya, Chernet, Ambahun, Sata, Eshetu, Zerihun, Mulat, Gessese, Demelash, Ayenew, Gedefaw, Ayele, Zebene, Melak, Berhanu, Haile, Mahteme, Zeru, Taye, Tadesse, Zerihun, Arnold, Benjamin F, Callahan, Elizabeth Kelly, Martin, Diana L
• Format: Journal Article
• Language: English
• Published: United States Institute of Tropical Medicine 01.01.2021; The American Society of Tropical Medicine and Hygiene
• Subjects: Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - therapeutic use; Antibodies; Antibodies, Bacterial; Child; Child, Preschool; Chlamydia; Chlamydia trachomatis - isolation & purification; Condoms; Ethiopia - epidemiology; Female; Humans; Infant; Infections; Male; Mass Drug Administration; Population Surveillance; Prevalence; Trachoma - epidemiology; Trachoma - microbiology; Ethiopia
• ISSN: 0002-9637; 1476-1645
• DOI: 10.4269/AJTMH.20-0777

The Trachoma Control Program in Amhara region, Ethiopia, scaled up the surgery, antibiotics, facial cleanliness, and environmental improvement (SAFE) strategy in all districts starting in 2007. Despite these efforts, many districts still require additional years of SAFE. In 2017, four districts were selected for the assessment of antibody responses against antigens and infection to better understand transmission. Districts with differing endemicity were chosen, whereby one had a previous trachomatous inflammation-follicular (TF) prevalence of ≥ 30% (Andabet), one had a prevalence between 10% and 29.9% (Dera), one had a prevalence between 5% and 10% (Woreta town), and one had a previous TF prevalence of < 5% (Alefa) and had not received antibiotic intervention for 2 years. Survey teams assessed trachoma clinical signs and took conjunctival swabs and dried blood spots (DBS) to measure infection and antibody responses. Trachomatous inflammation-follicular prevalence among children aged 1-9 years was 37.0% (95% CI: 31.1-43.3) for Andabet, 14.7% (95% CI: 10.0-20.5) for Dera, and < 5% for Woreta town and Alefa. infection was only detected in Andabet (11.3%). Within these districts, 2,195 children provided DBS. The prevalence of antibody responses to the antigen Pgp3 was 36.9% (95% CI: 29.0-45.6%) for Andabet, 11.3% (95% CI: 5.9-20.6%) for Dera, and < 5% for Woreta town and Alefa. Seroconversion rate for Pgp3 in Andabet was 0.094 (95% CI: 0.069-0.128) events per year. In Andabet district, where SAFE implementation has occurred for 11 years, the antibody data support the finding of persistently high levels of trachoma transmission.